Delivery Order SPE2DB20D7061-SPE2DB25FSPE2
- Not listed
- The Defense Logistics Agency awarded a $1,630.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sodium Bicarbonate 8.4% Syringe 50ML, with an ultimate completion date of September 29, 2025. This non-set-aside contract, awarded on September 26, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,868.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sodium Bicarbonate 8.4% syringes in 50ml quantities. This non-set-aside contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a small-value medical supply delivery under the company's existing pharmaceutical procurement framework. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Sodium Bicarbonate 8.4% syringes in 50-milliliter units. This is a firm fixed-price delivery order with a ceiling value of $1,601.47 and an ultimate completion date of October 1, 2025. The award represents a non-competitive procurement and is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Sodium Bicarbonate 8.4% syringes in 50mL quantities. The contract is valued at $1,069.10 with a firm fixed price structure and carries no set-aside designation, indicating it was competitively awarded. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Sodium Bicarbonate 8.4% vials (50mL) with a ceiling value of $1,943.32. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 21, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $103,340 delivery order to Amerisourcebergen Drug Corporation for sodium bicarbonate syringes. Under the firm fixed price contract, Amerisourcebergen will provide 50 milliliter syringes of the 8.4% sodium bicarbonate solution. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all items to be delivered between July 3rd and July 5th, 2023. No additional details were provided regarding the original solicitation...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.75 to AmerisourceBergen Drug Corp for sodium bicarbonate 8.4% vials in 50ml quantities. This firm fixed price contract, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Sodium Bicarbonate 8.4% Vial 50ML pharmaceutical product with a ceiling value of $8,130.14. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Sodium Bicarbonate 4.2% Vial 5mL, with a contract ceiling value of $4,731.23. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025. The contract was not set aside for small businesses or other designated categories and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Sodium Bicarbonate 8.4% in 50ml vials with a ceiling value of $1,087.93. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, representing a child contract under AmerisourceBergen's broader pharmaceutical supply agreement. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPE2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,984.62 to AmerisourceBergen Drug Corp for the supply of Sodium Bicarbonate 8.4% syringes in 50mL units. This competitive contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. Sodium bicarbonate is a critical emergency pharmaceutical used in military medical settings for treating severe metabolic acidosis and other acute medical conditions, making this commodity essential to the Defense Health Agency and broader military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 8/8/25 |